Although I agree I'd like to see a big pipeline I think that will come in time. Remembering ACRUX own the technology and either need to acquire the rights to the drugs or partner with someone. As for partnering I think they are tying in nicely with Lily. I think what everyone is waiting for is the confirmation that the using public will adopt the application system over gels, patches etc and possibly tablets and are waiting to see Axiron prove this. If it does, IMO you will see leaps and bounds or then possibly take over interest.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.6¢ |
Change
-0.001(5.88%) |
Mkt cap ! $6.524M | |||
| Open | High | Low | Value | Volume |
| 1.7¢ | 1.7¢ | 1.5¢ | $19.90K | 1.210M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 463664 | 1.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.7¢ | 320000 | 2 |
View Market Depth
| Last trade - 15.56pm 25/06/2025 (20 minute delay) ? |
| ACR (ASX) Chart |